Company CVAbout Ambalal Sarabhai Enterprises Ltd 
Ambalal Sarabhai Enterprises Ltd
Micro Cap
Pharmaceuticals & Drugs
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally.
Company Coordinates
Company Details
Shanti Sadan, Mirzapur Road Ahmedabad Gujarat : 380001
Registrar Details
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Sarabhai Holdings Private Limited (25.76%)
Highest Public shareholder
Haryana Containers Limited (1.61%)
Individual Investors Holdings
57.08%
Board of Directors
Management
Designation
Remuneration
Kartikeya V Sarabhai
Chairman & Wholetime Director
57.81 lacs
Anil H Parekh
Non Executive Director
35.0 k
Ashwin P Hathi
Independent Director
70.0 k
Chaula Shastri
Whole-time Director
38.99 lacs
Chandrashekhar B. Bohra
Independent Director
55.0 k
Damodar Sejpal
Company Sec. & Compli. Officer
0
Mayur K Swedia
Independent Director
1.6 lacs
BRIJESH KHANDELWAL
Director
0
BRIJESH KHANDELWAL
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
46 Cr
(Quarterly Results - Dec 2024)
Net Profit:
2 Cr
Pharmaceuticals & Drugs
INR 295 Cr (Micro Cap)
20.00
33
0.00%
0.18
9.49%
2.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
